Gut Microbes and Health Programme, Quadram Institute Bioscience, Norwich Research Park, Norwich, UK.
Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, UK.
Emerg Microbes Infect. 2018 Aug 6;7(1):141. doi: 10.1038/s41426-018-0144-8.
Clostridium perfringens, a rapid-growing pathogen known to secrete an arsenal of >20 virulent toxins, has been associated with intestinal diseases in both animals and humans throughout the past century. Recent advances in genomic analysis and experimental systems make it timely to re-visit this clinically and veterinary important pathogen. This Review will summarise our understanding of the genomics and virulence-linked factors, including antimicrobial potentials and secreted toxins of this gut pathogen, and then its up-to-date clinical epidemiology and biological role in the pathogenesis of several important human and animal-associated intestinal diseases, including pre-term necrotising enterocolitis. Finally, we highlight some of the important unresolved questions in relation to C. perfringens-mediated infections, and implications for future research directions.
产气荚膜梭菌是一种生长迅速的病原体,已知能分泌 20 多种毒力毒素,在上个世纪一直与动物和人类的肠道疾病有关。基因组分析和实验系统的最新进展使得重新审视这种具有临床和兽医重要性的病原体成为可能。本综述将总结我们对该肠道病原体的基因组学和与毒力相关因素的理解,包括其抗菌潜力和分泌的毒素,然后总结其最新的临床流行病学和在几种重要的人类和动物相关肠道疾病(包括早产儿坏死性小肠结肠炎)发病机制中的生物学作用。最后,我们强调了与产气荚膜梭菌介导的感染相关的一些重要未解决的问题及其对未来研究方向的影响。